Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Tumeurs solides
- | Specialty : -
Extract
A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate Midazolam in Patients With ALK-Positive or ROS1-Positive Solid Tumors